Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CITRUS
NCT02350959Phase 4Unknown
- Sponsor
- NHIS Ilsan Hospital
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in coronary artery disease (CAD) (2 arms), sponsored by NHIS Ilsan Hospital. Primary endpoints: Change of max Lipid core burden index in 4 mm at 1 year and Correlation between vulnerable plaque on CT and max LCBI(4mm) at 3 months. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02350959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350959.